A Phase I Study of IBI325 in Patients With Advanced Solid Tumor
Clinical trial NCT05119998 · COMPLETED
Trial details
- NCT number
- NCT05119998
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-08
- Primary completion
- 2023-07-27
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.